Latest news

AstraZeneca’s Strategic Leap into KRAS G12D with Chinese Biotech Collaboration

AstraZeneca has secured a significant deal in the competitive field of cancer research, specifically focusing on a...

GSK Drops Bowel Disease Asset Amid Immunology Unit Changes

GlaxoSmithKline (GSK) has jolted the pharmaceutical community with its abrupt decision to sever ties with Sosei Heptares,...

InDex’s Ulcerative Colitis Drug Experiences Failure in Phase 3 Review

The Swedish biotech InDex has delivered surprising news to investors, announcing the premature termination of a phase...

Novo Nordisk announces €2.1 billion commitment to France

Novo Nordisk has announced a substantial investment of €2.1 billion to expand its production facility in Chartres,...

Merck to Purchase Caraway Therapeutics For Over $600M

Merck & Co. has openly expressed its...

NanoString Faces Setback in Patent Infringement Case Against Genomics

In a recent legal skirmish in the biotechnology sector, NanoString finds itself on the losing end of...

Setback for Bayer as Promising Anti-Clotting Drug Trials Halted

In a significant setback for Germany's pharmaceutical giant Bayer, the company has halted a large late-stage trial...

Karuna Therapeutics Phase 1b Trial Results Reinforce Cardiovascular Safety of Schizophrenia Treatment KarXT

The  Phase 1b unrestricted-label, eight-week residential trial meant to assess the influence of KarXT (xanomeline-trospium) on round-the-clock...

Lilly plans to construct a $2.5 billion manufacturing facility in Germany

Eli Lilly, a U.S.-based pharmaceutical company, has...

Gilead gives Arcellx $285 million to extend agreement for BCMA cell treatment

Gilead Sciences subsidiary, Kite Pharma, is allocating...

FDA Expresses Doubt Over Merck’s Cough Candidate

Merck & Co. is racing against the clock to launch the first medication for chronic coughing on...

New York University Study Finds Prominent Breakthrough for Pain Management; Outperforms Pain Drug

Researchers at New York University have made an important discovery in the field of pain management, revealing...

Pfizer’s Cost-Cutting Measures Impact UK’s Sandwich Site, Leading to Job Loss for 500 Employees

Earlier this month, Pfizer, the pharmaceutical giant, extended its cost-cutting endeavors beyond its domestic borders, reaching Ireland....

Celltrion Healthcare introduces a biosimilar version of Humira called Yuflyma, in the US

Celltrion Healthcare, a biopharmaceutical company based in...

Care Management Program for Complex & Rare Conditions Launched by Accredo

Evernorth, a subsidiary of the healthcare company...

Popular

Most popular life news you must read today

NRx Pharma’s ZYESAMI™ approved for emergency use Covid critical care in Georgia

As of July 27, a global biopharmaceutical company, NRx Pharmaceuticals, has announced that the Prime Minister of the Nation of Georgia

Vertex scores FDA nod for kids’ cystic fibrosis drug Trikafta

Trikafta was approved by FDA for the treatment of Cystic Fibrosis in patients aged 6 to 11 years, after receiving approval to be used in patients of ages 12 and up

Commercial

AstraZeneca’s Strategic Leap into KRAS G12D with Chinese Biotech Collaboration

AstraZeneca has secured a significant deal in the competitive field of cancer research, specifically focusing on a...

GSK Drops Bowel Disease Asset Amid Immunology Unit Changes

GlaxoSmithKline (GSK) has jolted the pharmaceutical community with its abrupt decision to sever ties with Sosei Heptares,...

Novo Nordisk Set to Slash Victoza Production to Boost Ozempic Supply

In response to the escalating demand for its GLP-1 weight loss products, Novo Nordisk is adopting a...

Merck to Purchase Caraway Therapeutics For Over $600M

Merck & Co. has openly expressed its continuous pursuit of acquisitions, and currently, the prominent pharmaceutical company...

NanoString Faces Setback in Patent Infringement Case Against Genomics

In a recent legal skirmish in the biotechnology sector, NanoString finds itself on the losing end of...

Gilead gives Arcellx $285 million to extend agreement for BCMA cell treatment

Gilead Sciences subsidiary, Kite Pharma, is allocating $285 million towards advancing its pursuit of BCMA through a...

Information Technology

Siemens Healthineers & Qure.ai partnership Aims to Enhance Tuberculosis Diagnosis Using AI

Siemens Healthineers, in collaboration with Qure.ai and the Global Fund to Combat...

Philips Launches New Platform to Improve Health Monitoring

Over two years following the acquisition of the medical information aggregator Capsule...

Zeiss and Boehringer Ingelheim have formed an AI-backed alliance

A recently established collaboration between Zeiss Medical Technology and Boehringer Ingelheim is...

Trialbee’s new tool aims to expedite clinical trial recruitment delays

Clinical trials play a pivotal role in advancing medical research and the...

Regulatory

FDA Expresses Doubt Over Merck’s Cough Candidate

Merck & Co. is racing against the...

GSK Drops Bowel Disease Asset Amid Immunology Unit Changes

GlaxoSmithKline (GSK) has jolted the pharmaceutical community...

InDex’s Ulcerative Colitis Drug Experiences Failure in Phase 3 Review

The Swedish biotech InDex has delivered surprising...

Novo Nordisk announces €2.1 billion commitment to France

Novo Nordisk has announced a substantial investment...

Life Sciences Voice Top Five Newsletter

Welcome to the latest edition of the...

Research & Development

New York University Study Finds Prominent Breakthrough for Pain Management; Outperforms Pain Drug

Researchers at New York University have made an important discovery in the...

EnginZyme Utilizes Biocatalysis to Manufacture Essential Component for mRNA Vaccines

EnginZyme AB, a cutting-edge technology company specializing in enzymatic biomanufacturing, has successfully...

Overcoming Age-Related Challenges in Nanodrug Delivery for Pediatric Cancer Patients

The efficacy of medical treatments often varies with age, and this principle...

Market Access

Novo Nordisk announces €2.1 billion commitment to France

Novo Nordisk has announced a substantial investment of €2.1 billion to expand...

Lilly plans to construct a $2.5 billion manufacturing facility in Germany

Eli Lilly, a U.S.-based pharmaceutical company, has announced plans to construct its...

Merck and Ginkgo Forge $490 Million Partnership to Enhance Biologics Manufacturing Efficiency

Merck has solidified a substantial collaboration valued at $490 million with Ginkgo...

Vertex and Lonza Join Forces to Open New Manufacturing Facility for the Former’s T1D Therapies

Vertex Pharmaceuticals and Lonza have announced a strategic partnership to construct a...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival